Download Free Sample Report

Opthalmic Pharmaceutical Drugs Market, Global Outlook and Forecast 2022-2028

Opthalmic Pharmaceutical Drugs Market, Global Outlook and Forecast 2022-2028

  • Published on : 12 July 2022
  • Pages :70
  • Report Code:SMR-7202624

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
This report contains market size and forecasts of Opthalmic Pharmaceutical Drugs in global, including the following market information:
Global Opthalmic Pharmaceutical Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opthalmic Pharmaceutical Drugs Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Opthalmic Pharmaceutical Drugs companies in 2021 (%)
The global Opthalmic Pharmaceutical Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-glaucoma Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opthalmic Pharmaceutical Drugs include Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma and Topcon Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Opthalmic Pharmaceutical Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opthalmic Pharmaceutical Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Opthalmic Pharmaceutical Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-glaucoma
Anti-infection
Anti-inflammatory
Anti-allergy
Global Opthalmic Pharmaceutical Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Opthalmic Pharmaceutical Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores
Online Pharmacies
Others
Global Opthalmic Pharmaceutical Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Opthalmic Pharmaceutical Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opthalmic Pharmaceutical Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opthalmic Pharmaceutical Drugs revenues share in global market, 2021 (%)
Key companies Opthalmic Pharmaceutical Drugs sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Opthalmic Pharmaceutical Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Carl-Zeiss
Ellex Medical Lasers
Essilor International
Hoya Corporation
Insight Vision
Nidek
Novagali Pharma
Topcon Corporation
Ziemer Ophthalmic Systems